Investors & Media International Stem Cell Corporation's CEO Publishes Letter to Shareholders CEO Letter to Shareholders International Stem Cell Corporation to Raise $2.5 Million Through a Private Placement International Stem Cell Corporation Provides Update on the Status of Its Parkinson's Disease Program International Stem Cell Corporation to Present at Two Upcoming Investment Conferences International Stem Cell Corporation Provides R&D and Business Results for Second Quarter and First Half of 2014 International Stem Cell Corporation Launches Stroke Program With Tulane University International Stem Cell Corporation Secures Approval for Core Technology Patents in European Union Lifeline Cell Technology Expands Asian Distribution Network Lifeline Skin Care - July 2014 Update 6 7 8 9 10 11 12 13 14 15 16 << < > >>
